SANGAMO THERAPEUTICS, INC - COM (SGMO)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
55.9M
Holdings value Q3 2024
$48.4M
Value change Q3 2024
-$13.2M
Grand Portfolio weight change Q3 2024
0%
Number of holders
100
Number of buys Q3 2024
38
Number of sells Q3 2024
-71
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 55.9M $48.4M -$13.2M $0.87 101
2024 Q2 86.9M $31.1M -$5.53M $0.36 126
2024 Q1 100M $67.2M +$9.59M $0.67 126
2023 Q4 86.9M $47.2M -$9.27M $0.54 128
2023 Q3 102M $61.3M -$4.25M $0.60 130
2023 Q2 106M $137M -$10.8M $1.30 148
2023 Q1 112M $197M +$12M $1.76 178
2022 Q4 104M $326M +$18.1M $3.14 178
2022 Q3 97.3M $477M +$38.5M $4.90 188
2022 Q2 89.6M $371M +$44.1M $4.14 174
2022 Q1 79.9M $465M +$13.3M $5.81 184
2021 Q4 76.8M $577M +$14.7M $7.50 181
2021 Q3 75.2M $679M -$11.3M $9.01 184
2021 Q2 76.1M $911M -$39.6M $11.97 191
2021 Q1 79.3M $993M +$8.74M $12.53 190
2020 Q4 78.2M $1.22B -$2.92M $15.61 219
2020 Q3 81.6M $772M +$39.7M $9.45 202
2020 Q2 77M $690M +$38.3M $8.96 197
2020 Q1 74M $471M -$44.2M $6.37 173
2019 Q4 78.4M $656M -$35.5M $8.37 187
2019 Q3 82.1M $744M +$18.2M $9.05 178
2019 Q2 79.8M $860M +$188M $10.77 180
2019 Q1 65.9M $628M +$8.49M $9.54 177
2018 Q4 63.9M $734M -$24.5M $11.48 187
2018 Q3 64.6M $1.1B +$6.26M $16.95 216
2018 Q2 64.7M $919M +$102M $14.20 209
2018 Q1 57.2M $1.09B +$32.1M $19.00 207
2017 Q4 55.6M $911M +$36.6M $16.40 168
2017 Q3 54.7M $820M +$37.4M $15.00 148
2017 Q2 53M $467M +$101M $8.80 143
2017 Q1 41.8M $218M +$36.2M $5.20 116
2016 Q4 41.2M $126M -$12.2M $3.05 121
2016 Q3 43.6M $202M -$12.3M $4.63 121
2016 Q2 46.2M $268M -$15.6M $5.79 136
2016 Q1 48.7M $292M -$4.35M $6.05 142
2015 Q4 48.8M $445M -$26.2M $9.13 138
2015 Q3 52.7M $297M -$28.7M $5.64 143
2015 Q2 50.5M $560M -$37.9M $11.09 157
2015 Q1 52.3M $819M +$52.3M $15.68 168
2014 Q4 47.6M $724M -$12.2M $15.21 159
2014 Q3 48.5M $523M -$10.7M $10.79 158
2014 Q2 48.9M $746M -$18.5M $15.27 155
2014 Q1 48.3M $872M +$52.9M $18.08 150